Company filings profile · CIK 0002007919
Inhibrx Biosciences, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Inhibrx Biosciences, Inc. (INBX): 26 filings in the last 90 days vs 16 in the prior 90 (filing-velocity rising ↑ · 1.63×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 29, 2026. Source-linked, daily-refreshed.
Material 8-K events — Inhibrx Biosciences, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 28, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Sep 8, 2026 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Aug 13, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 16, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 15, 2026 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Jun 3, 2026 | Item 5.07 | ↗ |
| May 14, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| May 11, 2026 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
Watch Inhibrx Biosciences, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 28, 2026 | 4 | FORM 4 | ↗ |
| Sep 28, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Sep 23, 2026 | 4 | FORM 4 | ↗ |
| Sep 18, 2026 | 4/A | FORM 4/A | ↗ |
| Sep 18, 2026 | 4/A | FORM 4/A | ↗ |
| Sep 18, 2026 | 4/A | FORM 4/A | ↗ |
| Sep 18, 2026 | 4/A | FORM 4/A | ↗ |
| Sep 17, 2026 | 4 | FORM 4 | ↗ |
| Sep 15, 2026 | 4 | FORM 4 | ↗ |
| Sep 15, 2026 | 144 | ↗ | |
| Sep 14, 2026 | 144 | ↗ | |
| Sep 11, 2026 | 144 | ↗ | |
| Sep 10, 2026 | 4 | FORM 4 | ↗ |
| Sep 9, 2026 | 144 | ↗ | |
| Sep 8, 2026 | 144 | ↗ | |
| Sep 8, 2026 | 4 | FORM 4 | ↗ |
| Sep 8, 2026 | 4 | FORM 4 | ↗ |
| Sep 8, 2026 | 4 | FORM 4 | ↗ |
| Sep 8, 2026 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 14, 2026 | SCHEDULE 13G | ↗ | |
| Aug 14, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 13, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 13, 2026 | 10-Q | 10-Q | ↗ |
| Aug 3, 2026 | SCHEDULE 13G | ↗ | |
| Jul 16, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 15, 2026 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Jun 4, 2026 | 4 | FORM 4 | ↗ |
| Jun 4, 2026 | 4 | FORM 4 | ↗ |
| Jun 4, 2026 | 4 | FORM 4 | ↗ |
| Jun 4, 2026 | 4 | FORM 4 | ↗ |
| Jun 3, 2026 | 8-K | Item 5.07 | ↗ |
| May 15, 2026 | SCHEDULE 13G/A | ↗ | |
| May 15, 2026 | SCHEDULE 13G/A | ↗ | |
| May 14, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| May 14, 2026 | 10-Q | 10-Q | ↗ |
| May 11, 2026 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Apr 27, 2026 | 4 | FORM 4 | ↗ |
| Apr 23, 2026 | ARS | ARS | ↗ |
| Apr 23, 2026 | DEFA14A | DEFA14A | ↗ |